Movement Alert|Texas Instruments Rises 3.14% in Pre-Market Trading, Q2 Earnings Release Imminent as Multiple Brokerages Raise Price Targets

Market Focus
Jul 21

On July 21, Texas Instruments rose 3.14% in pre-market trading, trading at $293.0/share, with turnover of approximately $498,000.

On the news front, the company is scheduled to report Q2 earnings after market close on July 22. Market consensus expects quarterly revenue of $5.246 billion, representing a 20.41% year-over-year increase, with adjusted EPS of $1.93, up 42.77% year-over-year. The anticipation of strong results has attracted buying interest ahead of the release.

Adding to the bullish sentiment, multiple brokerages have recently raised their price targets on the stock. KeyBanc raised its target from $325 to $390 maintaining an overweight rating, TD Cowen increased from $300 to $360 maintaining a buy rating, UBS lifted from $295 to $350 maintaining a buy rating, and Cantor Fitzgerald adjusted from $300 to $340. Morgan Stanley also raised its target modestly from $221 to $230 but maintained an underweight rating. The FactSet consensus mean price target now stands at $309.72 with an average overweight rating.

Additionally, nearly 20 analog and power semiconductor companies launched a new round of price increases effective July 1, with multiple manufacturers citing full order books and improved capacity visibility, providing a favorable industry backdrop.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10